Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
oseni
Synonyms :
alogliptin/pioglitazone
Class :
Anti-diabetics, thiazolidinediones
Brand Name :
oseni
Synonyms :
alogliptin/pioglitazone
Class :
Anti-diabetics, thiazolidinediones
Dosage Forms & StrengthsÂ
TabletÂ
12.5mg/15mgÂ
12.5mg/30mgÂ
12.5mg/40mgÂ
25mg/15mgÂ
25mg/30mgÂ
25mg/45mgÂ
In individuals with type 2 diabetes mellitus, it is recommended as a supplement to diet and exercise to improve glycemic control
may enhance the serum concentration
may enhance the serum concentration
may enhance the serum concentration
may increase the hypoglycemic effect of Anti-diabetic Agents
may diminish the serum concentration
may decrease the therapeutic effect of Anti-diabetic Agents
may increase the therapeutic effect of Anti-diabetic Agents
may increase the therapeutic effect of Anti-diabetic Agents
may increase the hypoglycaemic effect of anti-diabetic agents
may increase the hypoglycaemic effect of anti-diabetic agents
may increase the hypoglycaemic effect of anti-diabetic agents
Frequency defined:Â Â
>10%Â
EdemaÂ
Worsening chronic heart failureÂ
1-10%Â
Upper respiratory tract infectionÂ
NasopharyngitisÂ
Back painÂ
HypoglycemiaÂ
<1%Â
PancreatitisÂ
HypersensitivityÂ
Post-marketing reportsÂ
IleusÂ
RhabdomyolysisÂ
NauseaÂ
DiarrheaÂ
AngioedemaÂ
UrticariaÂ
Hepatic failureÂ
Stevens-Johnson syndromeÂ
ArthralgiaÂ
Tubulointerstitial nephritisÂ
Pregnancy consideration: Insufficient data availableÂ
Lactation: Excretion of the drug in human breast milk is unknownÂ
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this categoryÂ
Patient information leafletÂ
Generic Name: alogliptin/pioglitazone Â
Pronounced: AL-oh-GLIP-tin/PYE-oh-GLI-ta-zoneÂ
Why do we use alogliptin/pioglitazone?Â
It is used to treat hyperglycemia in patients with type 2 diabetes mellitusÂ
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
